Sentieon Stock

Enable Precision Data for Precision Medicine

Sign up today and learn more about Sentieon Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Sentieon Stock

Sentieon develops and commercializes cloud-based bio-informatics solutions for the life sciences and clinical market. They develop and supply a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, accuracy, and consistency. Some of the released products include Sentieon DNAseq, a germline DNA pipeline; and Sentieon TNseq, for tumor-normal somatic variant detection. The company’s tools are scalable, deployable, upgradable, and software-only solutions. The Sentieon tools achieve their efficiency and consistency through optimized computing algorithm design and enterprise-strength software implementation. The company was founded by Jun Ye in 2014 and is headquartered in Mountain View, California.

Funding History

April 2014$3.8M
May 2015$20.0M


Co-Founder, President and CEO

Jun Ye


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: